Cargando…
A third high dose of inactivated COVID-19 vaccine induces higher neutralizing antibodies in humans against the Delta and Omicron variants: a Randomized, Double-Blinded Clinical Trial
| Autores principales: | , , , , , , , |
|---|---|
| Formato: | Online Artículo Texto |
| Lenguaje: | English |
| Publicado: |
Science China Press
2022
|
| Materias: | |
| Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9020148/ https://www.ncbi.nlm.nih.gov/pubmed/35441932 http://dx.doi.org/10.1007/s11427-022-2110-1 |
| _version_ | 1784689469995089920 |
|---|---|
| author | Cao, Yu Wang, Xiaoli Li, Siqi Dong, Yuan Liu, Yonghong Li, Jing Zhao, Yanqing Feng, Yingmei |
| author_facet | Cao, Yu Wang, Xiaoli Li, Siqi Dong, Yuan Liu, Yonghong Li, Jing Zhao, Yanqing Feng, Yingmei |
| author_sort | Cao, Yu |
| collection | PubMed |
| description | |
| format | Online Article Text |
| id | pubmed-9020148 |
| institution | National Center for Biotechnology Information |
| language | English |
| publishDate | 2022 |
| publisher | Science China Press |
| record_format | MEDLINE/PubMed |
| spelling | pubmed-90201482022-04-20 A third high dose of inactivated COVID-19 vaccine induces higher neutralizing antibodies in humans against the Delta and Omicron variants: a Randomized, Double-Blinded Clinical Trial Cao, Yu Wang, Xiaoli Li, Siqi Dong, Yuan Liu, Yonghong Li, Jing Zhao, Yanqing Feng, Yingmei Sci China Life Sci Letter to the Editor Science China Press 2022-04-15 2022 /pmc/articles/PMC9020148/ /pubmed/35441932 http://dx.doi.org/10.1007/s11427-022-2110-1 Text en © Science China Press and Springer-Verlag GmbH Germany, part of Springer Nature 2022 This article is made available via the PMC Open Access Subset for unrestricted research re-use and secondary analysis in any form or by any means with acknowledgement of the original source. These permissions are granted for the duration of the World Health Organization (WHO) declaration of COVID-19 as a global pandemic. |
| spellingShingle | Letter to the Editor Cao, Yu Wang, Xiaoli Li, Siqi Dong, Yuan Liu, Yonghong Li, Jing Zhao, Yanqing Feng, Yingmei A third high dose of inactivated COVID-19 vaccine induces higher neutralizing antibodies in humans against the Delta and Omicron variants: a Randomized, Double-Blinded Clinical Trial |
| title | A third high dose of inactivated COVID-19 vaccine induces higher neutralizing antibodies in humans against the Delta and Omicron variants: a Randomized, Double-Blinded Clinical Trial |
| title_full | A third high dose of inactivated COVID-19 vaccine induces higher neutralizing antibodies in humans against the Delta and Omicron variants: a Randomized, Double-Blinded Clinical Trial |
| title_fullStr | A third high dose of inactivated COVID-19 vaccine induces higher neutralizing antibodies in humans against the Delta and Omicron variants: a Randomized, Double-Blinded Clinical Trial |
| title_full_unstemmed | A third high dose of inactivated COVID-19 vaccine induces higher neutralizing antibodies in humans against the Delta and Omicron variants: a Randomized, Double-Blinded Clinical Trial |
| title_short | A third high dose of inactivated COVID-19 vaccine induces higher neutralizing antibodies in humans against the Delta and Omicron variants: a Randomized, Double-Blinded Clinical Trial |
| title_sort | third high dose of inactivated covid-19 vaccine induces higher neutralizing antibodies in humans against the delta and omicron variants: a randomized, double-blinded clinical trial |
| topic | Letter to the Editor |
| url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9020148/ https://www.ncbi.nlm.nih.gov/pubmed/35441932 http://dx.doi.org/10.1007/s11427-022-2110-1 |
| work_keys_str_mv | AT caoyu athirdhighdoseofinactivatedcovid19vaccineinduceshigherneutralizingantibodiesinhumansagainstthedeltaandomicronvariantsarandomizeddoubleblindedclinicaltrial AT wangxiaoli athirdhighdoseofinactivatedcovid19vaccineinduceshigherneutralizingantibodiesinhumansagainstthedeltaandomicronvariantsarandomizeddoubleblindedclinicaltrial AT lisiqi athirdhighdoseofinactivatedcovid19vaccineinduceshigherneutralizingantibodiesinhumansagainstthedeltaandomicronvariantsarandomizeddoubleblindedclinicaltrial AT dongyuan athirdhighdoseofinactivatedcovid19vaccineinduceshigherneutralizingantibodiesinhumansagainstthedeltaandomicronvariantsarandomizeddoubleblindedclinicaltrial AT liuyonghong athirdhighdoseofinactivatedcovid19vaccineinduceshigherneutralizingantibodiesinhumansagainstthedeltaandomicronvariantsarandomizeddoubleblindedclinicaltrial AT lijing athirdhighdoseofinactivatedcovid19vaccineinduceshigherneutralizingantibodiesinhumansagainstthedeltaandomicronvariantsarandomizeddoubleblindedclinicaltrial AT zhaoyanqing athirdhighdoseofinactivatedcovid19vaccineinduceshigherneutralizingantibodiesinhumansagainstthedeltaandomicronvariantsarandomizeddoubleblindedclinicaltrial AT fengyingmei athirdhighdoseofinactivatedcovid19vaccineinduceshigherneutralizingantibodiesinhumansagainstthedeltaandomicronvariantsarandomizeddoubleblindedclinicaltrial AT caoyu thirdhighdoseofinactivatedcovid19vaccineinduceshigherneutralizingantibodiesinhumansagainstthedeltaandomicronvariantsarandomizeddoubleblindedclinicaltrial AT wangxiaoli thirdhighdoseofinactivatedcovid19vaccineinduceshigherneutralizingantibodiesinhumansagainstthedeltaandomicronvariantsarandomizeddoubleblindedclinicaltrial AT lisiqi thirdhighdoseofinactivatedcovid19vaccineinduceshigherneutralizingantibodiesinhumansagainstthedeltaandomicronvariantsarandomizeddoubleblindedclinicaltrial AT dongyuan thirdhighdoseofinactivatedcovid19vaccineinduceshigherneutralizingantibodiesinhumansagainstthedeltaandomicronvariantsarandomizeddoubleblindedclinicaltrial AT liuyonghong thirdhighdoseofinactivatedcovid19vaccineinduceshigherneutralizingantibodiesinhumansagainstthedeltaandomicronvariantsarandomizeddoubleblindedclinicaltrial AT lijing thirdhighdoseofinactivatedcovid19vaccineinduceshigherneutralizingantibodiesinhumansagainstthedeltaandomicronvariantsarandomizeddoubleblindedclinicaltrial AT zhaoyanqing thirdhighdoseofinactivatedcovid19vaccineinduceshigherneutralizingantibodiesinhumansagainstthedeltaandomicronvariantsarandomizeddoubleblindedclinicaltrial AT fengyingmei thirdhighdoseofinactivatedcovid19vaccineinduceshigherneutralizingantibodiesinhumansagainstthedeltaandomicronvariantsarandomizeddoubleblindedclinicaltrial |